NCT05170828 2026-02-24Cryopreserved MMUD BM With PTCy for Hematologic MalignanciesOssium Health, Inc.Phase 1 Withdrawn
NCT04848064 2026-02-10Third-Party Natural Killer Cells and Mogamulizumab for the Treatment of Relapsed or Refractory Cutaneous T-cell Lymphomas or Adult T-Cell Leukemia/LymphomaOhio State University Comprehensive Cancer CenterPhase 1 Recruiting12 enrolled